1 - 25 of 87 results for author:"Oren M." in Literature citations
Results Customize
› Repeat search in UniProtKB (25)
| RNF20 and USP44 regulate stem cell differentiation by modulating H2B monoubiquitylation. Fuchs G., Shema E., Vesterman R., Kotler E., Wolchinsky Z., Wilder S., Golomb L., Pribluda A., Zhang F., Haj-Yahya M. et al. |
| Importin 7 and exportin 1 link c-Myc and p53 to regulation of ribosomal biogenesis. Golomb L., Bublik D.R., Wilder S., Nevo R., Kiss V., Grabusic K., Volarevic S., Oren M. Mol. Cell 45:222-232(2012) · Mapped (7) |
| RNF20-RNF40: A ubiquitin-driven link between gene expression and the DNA damage response. Shiloh Y., Shema E., Moyal L., Oren M. FEBS Lett. 585:2795-2802(2011) · Mapped (12) |
| Two phases of mitogenic signaling unveil roles for p53 and EGR1 in elimination of inconsistent growth signals. Zwang Y., Sas-Chen A., Drier Y., Shay T., Avraham R., Lauriola M., Shema E., Lidor-Nili E., Jacob-Hirsch J., Amariglio N. et al. Mol. Cell 42:524-535(2011) · Mapped (36) |
| RNF20 inhibits TFIIS-facilitated transcriptional elongation to suppress pro-oncogenic gene expression. Shema E., Kim J., Roeder R.G., Oren M. Mol. Cell 42:477-488(2011) · Mapped (6) |
| Carcinogen-induced hepatic tumors in KLF6+/- mice recapitulate aggressive human hepatocellular carcinoma associated with p53 pathway deregulation. Tarocchi M., Hannivoort R., Hoshida Y., Lee U.E., Vetter D., Narla G., Villanueva A., Oren M., Llovet J.M., Friedman S.L. Hepatology 54:522-531(2011) · Mapped (5) |
| Requirement of ATM-dependent monoubiquitylation of histone H2B for timely repair of DNA double-strand breaks. Moyal L., Lerenthal Y., Gana-Weisz M., Mass G., So S., Wang S.Y., Eppink B., Chung Y.M., Shalev G., Shema E. et al. Mol. Cell 41:529-542(2011) · Mapped (1) |
| ChIP-on-chip analysis of in vivo mutant p53 binding to selected gene promoters. Dell'Orso S., Fontemaggi G., Stambolsky P., Goeman F., Voellenkle C., Levrero M., Strano S., Rotter V., Oren M., Blandino G. OMICS 15:305-312(2011) · Mapped (34) |
| CKIalpha ablation highlights a critical role for p53 in invasiveness control. Elyada E., Pribluda A., Goldstein R.E., Morgenstern Y., Brachya G., Cojocaru G., Snir-Alkalay I., Burstain I., Haffner-Krausz R., Jung S. et al. Nature 470:409-413(2011) · Mapped (18) |
| A novel Chk1/2-Lats2-14-3-3 signaling pathway regulates P-body formation in response to UV damage. Okada N., Yabuta N., Suzuki H., Aylon Y., Oren M., Nojima H. J. Cell. Sci. 124:57-67(2011) · Mapped (19) |
| The Lats2 tumor suppressor augments p53-mediated apoptosis by promoting the nuclear proapoptotic function of ASPP1. Aylon Y., Ofir-Rosenfeld Y., Yabuta N., Lapi E., Nojima H., Lu X., Oren M. Genes Dev. 24:2420-2429(2010) · Mapped (37) |
| p53 status in stromal fibroblasts modulates tumor growth in an SDF1-dependent manner. Addadi Y., Moskovits N., Granot D., Lozano G., Carmi Y., Apte R.N., Neeman M., Oren M. Cancer Res. 70:9650-9658(2010) · Mapped (34) |
| p53-dependent regulation of autophagy protein LC3 supports cancer cell survival under prolonged starvation. Scherz-Shouval R., Weidberg H., Gonen C., Wilder S., Elazar Z., Oren M. Proc. Natl. Acad. Sci. U.S.A. 107:18511-18516(2010) · Mapped (45) |
| p53 binds preferentially to genomic regions with high DNA-encoded nucleosome occupancy. Lidor Nili E., Field Y., Lubling Y., Widom J., Oren M., Segal E. Genome Res. 20:1361-1368(2010) · Mapped (32) |
| Interference with the p53 family network contributes to the gain of oncogenic function of mutant p53 in hepatocellular carcinoma. Schilling T., Kairat A., Melino G., Krammer P.H., Stremmel W., Oren M., Muller M. Biochem. Biophys. Res. Commun. 394:817-823(2010) · Mapped (32) |
| Modulation of the vitamin D3 response by cancer-associated mutant p53. Stambolsky P., Tabach Y., Fontemaggi G., Weisz L., Maor-Aloni R., Siegfried Z., Sigfried Z., Shiff I., Kogan I., Shay M. et al. Cancer Cell 17:273-285(2010) · Mapped (32) |
| Mutant p53 gain-of-function in cancer. Oren M., Rotter V. Cold Spring Harb Perspect Biol 2:a001107-a001107(2010) · Mapped (32) |
| Silencing of the Lats2 tumor suppressor overrides a p53-dependent oncogenic stress checkpoint and enables mutant H-Ras-driven cell transformation. Aylon Y., Yabuta N., Besserglick H., Buganim Y., Rotter V., Nojima H., Oren M. Oncogene 28:4469-4479(2009) · Mapped (42) |
| p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC. Christoffersen N.R., Shalgi R., Frankel L.B., Leucci E., Lees M., Klausen M., Pilpel Y., Nielsen F.C., Oren M., Lund A.H. Cell Death Differ. 17:236-245(2010) · Mapped (7) |
| CDK9 directs H2B monoubiquitination and controls replication-dependent histone mRNA 3'-end processing. Pirngruber J., Shchebet A., Schreiber L., Shema E., Minsky N., Chapman R.D., Eick D., Aylon Y., Oren M., Johnsen S.A. |
| Cancer cells suppress p53 in adjacent fibroblasts. Bar J., Feniger-Barish R., Lukashchuk N., Shaham H., Moskovits N., Goldfinger N., Simansky D., Perlman M., Papa M., Yosepovich A. et al. Oncogene 28:933-936(2009) · Mapped (50) |
| p53-Repressed miRNAs are involved with E2F in a feed-forward loop promoting proliferation. Brosh R., Shalgi R., Liran A., Landan G., Korotayev K., Nguyen G.H., Enerly E., Johnsen H., Buganim Y., Solomon H. et al. Mol. Syst. Biol. 4:229-229(2008) · Mapped (34) |
| Mdm2 regulates p53 mRNA translation through inhibitory interactions with ribosomal protein L26. Ofir-Rosenfeld Y., Boggs K., Michael D., Kastan M.B., Oren M. Mol. Cell 32:180-189(2008) · Mapped (34) |
| The histone H2B-specific ubiquitin ligase RNF20/hBRE1 acts as a putative tumor suppressor through selective regulation of gene expression. Shema E., Tirosh I., Aylon Y., Huang J., Ye C., Moskovits N., Raver-Shapira N., Minsky N., Pirngruber J., Tarcic G. et al. Genes Dev. 22:2664-2676(2008) · Mapped (3) |
| Fbw7 regulates the activity of endoreduplication mediators and the p53 pathway to prevent drug-induced polyploidy. Finkin S., Aylon Y., Anzi S., Oren M., Shaulian E. Oncogene 27:4411-4421(2008) · Mapped (38) |